New

Trackinsight Enterprise, a unified platform for institutional ETF research, analytics, and compliance, is now live. Explore Trackinsight Enterprise →

Help us improve your experience. Please confirm your investor type:

ETF What's Up

Don’t Miss a Move in the ETF Market

Sign up and keep track of everything that moved the ETF industry this week. From new launches to regulatory shifts across the Atlantic.

ETF What's Up

You may unsubscribe at any time by clicking the “unsubscribe” link within the emailed newsletter. By signing up, you agree to our Privacy Policy and Terms and Conditions.

ETF ProvidersTidalPBPH
PBPH
US88635A2042
Passive ETFEquity

PBPH ETF · Portfolio Building Block World Pharma and Biotech Index ETF

The PBPH Exchange Traded Fund (ETF) is provided by Tidal. It is built to track an index: BITA Global Pharma and Biotech Select Index. The PBPH ETF provides physical exposure, so by buying it you actually own parts of all the 49 underlying holdings. This share class generates a stream of income by distributing dividends.
Last update Yesterday at 1:30 PM UTC
LIVE
CLOSED
This fund is part ofDM Large & Mid Cap1M perf.-3.38%
Last price
$26.02
1M perf.
-3.06%
1M flows
+€557M
AuM
€586M
E/R
0.13%
Rating
Not rated
ESG Consensus®
esg grade icon
PBPH
$26.02

Performance & flows

Segment for quartile rank
December 9, 2025 → March 9, 2026
002468101214%JANFEBMAR
Create a free account to view the flows graph
PBPH
$25.96
+7.45%
DM Large & Mid Cap
+6.31%

Historic performance and flows

1M3M1Y3Y5YMTDQTDYTD
Perf.
-3.06%
icon
+7.45%
icon
N/AN/AN/A
-4.48%
+3.00%
+3.00%
icon
Flows

Key fund info

Segment for quartile rank
This ETF's jurisdiction country is not in your region (Europe and Middle East) · 
Main characteristics
Issuer
CUSIP
88635A204
ISIN
US88635A2042
AuM
€586M
icon
E/R
0.13%
icon
Replication rating
Not rated
ESG Consensus®
esg grade icon
icon
More details
NAV
3/9/2026
$25.97
1D NAV change
+0.69%
Dividend policy
Replication method
Direct (Physical)
Replication model
Full replication
No. of holdings
49
Inception date
11/24/2025
Jurisdiction
United States
Distribution
United States
Legal structure
Open-end Investment Company
Base currency
USD
Dividend distribution
Trailing 12-month distr. yield
Distribution frequency
Last distribution
Create a free account to view dividend distribution
Classification
Product type
Benchmark
BITA Global Pharma and Biotech Select Index
Asset class
Factors
N/A
Investment strategy
The Portfolio Building Block World Pharma and Biotech Index ETF seeks to track the performance, before fees and expenses, of the BITA Global Pharma and Biotech Select Index (the “Index”).
Tax optimisation
PEA
France
UK Reporting Status
United Kingdom
Create a free Trackinsight Essentials account to unlock insights
Access exclusive metrics and features to support your investment decisions.
half moonhalf moon double
Built for professionals: access exclusive fund metrics and selection tools in Trackinsight Enterprise.
Enterprise Fund page features include:
Legal documents
Powerful buy-list integration
Fund data exports
Advanced risk metrics
Advanced replication analysis
Advanced exposure look-through
Upload your own internal metrics
Custom data feature
See all Trackinsight Enterprise features

Trackinsight
Enterprise

Trackinsight Enterprise helps professional and institutional ETF investors tackle operational, regulatory, and analytical challenges at every stage of the investment process.
Learn more about Trackinsight Enterprise

Similar ETFs in your region

WDHE
1M perf.
-2.38%
E/R
0.18%
IXJ
1M perf.
-2.78%
E/R
0.4%
IXJ
1M perf.
-3.75%
E/R
0.47%
XHC
1M perf.
-2.47%
E/R
0.66%
DRUG
1M perf.
-2.13%
E/R
0.57%

Advertisement

Risk profile

Segment for quartile rank

Historical risk/return profile

3M1Y3Y5Y
Returns
+7.45%
icon
N/A
N/A
N/A
Volatility
Perf./Volatility
Max drawdown
Create a free account to view risk/return table
Synthetic Risk and Reward Indicator (SRRI)
UCITS
N/A
PRIIPS
N/A
Built for professionals: access exclusive risk metrics in Trackinsight Enterprise.

Trackinsight
Enterprise

Trackinsight Enterprise helps professional and institutional ETF investors tackle operational, regulatory, and analytical challenges at every stage of the investment process.

Learn more about Trackinsight Enterprise

Exposure

Countries
USA
62.00%
Switzerland
11.74%
Denmark
4.83%
Japan
3.93%
United Kingdom
3.74%
France
2.49%
Germany
1.66%
Australia
1.41%
Unavailable
5.27%
Other
2.93%
Sectors
Health Care
88.00%
Consumer Staples
1.05%
Unavailable
10.96%
Diversification
Total weight of top 15 holdings out of 49
Top 15 holdings
Data as of January 31, 2026
LILLY
JOHNSON&JOHNSON
ABBVIE
ROCHE
NOVARTIS
MERCK & CO INC
DK0062498333
AMGEN-T
Create a free account to view top holdings
GILEAD SCIENCES
PFIZER
VERTEX PHARMACEUTICALS
BRISTOL-MYERS SQUIBB
SANOFI SA
GSK PLC
REGENERON PHARMACEUTICALS
Create a free account to view top holdings
Built for professionals: access exclusive exposure metrics in Trackinsight Enterprise.

Trackinsight
Enterprise

Trackinsight Enterprise helps professional and institutional ETF investors tackle operational, regulatory, and analytical challenges at every stage of the investment process.

Learn more about Trackinsight Enterprise

Sustainability

Integrates ESG criteria
No
SDG

ESG Consensus® by Conser

Data as of December 31, 2025
Methodology

Our partner Conser gathers the industry's consensus on the business practices of the underlying holdings. We have computed the following metrics about PBPH ETF's sustainability, based on their methodology.

Learn more about Conser

ESG Consensus®
esg grade icon

ESG Consensus® is based on the Final Sustainability Grade, which itself consists of 10 grades. Our partner Conser calculates the exact grade, based on market intelligence, using their proprietary ESG Consensus® methodology.


PBPH’s has a Final Sustainability Grade of either A+, A, or A-.

This fund’s exact Final Sustainability Grade is available in Trackinsight Enterprise.
Learn more about Trackinsight Enterprise
Holdings review
98.51% of holdings have positive scoring
7.05% of holdings have negative scoring
5.70%
78.68%
14.13%
Consensus levels
Strong
Medium
Weak
Built for professionals: access exclusive sustainability metrics in Trackinsight Enterprise.

Trackinsight
Enterprise

Trackinsight Enterprise helps professional and institutional ETF investors tackle operational, regulatory, and analytical challenges at every stage of the investment process.

Learn more about Trackinsight Enterprise

Replication

Trackinsight replication rating:
Not rated
Replication quality
Calculated over 12m, as of February 27, 2026
Tracking error
Tracking difference
Replication information
Index
BITA Global Pharma and Biotech Select GRT Index - USD
Index ticker
BWBLSI Index
Index dividend policy
GTR
Replication method
Replication model
Built for professionals: access exclusive replication metrics in Trackinsight Enterprise.

Trackinsight
Enterprise

Trackinsight Enterprise helps professional and institutional ETF investors tackle operational, regulatory, and analytical challenges at every stage of the investment process.

Learn more about Trackinsight Enterprise

Issuer

Frequently asked questions about PBPH

What does Portfolio Building Block World Pharma and Biotech Index ETF, PBPH, invest in?

PBPH is a Passive ETF. This ETF provides exposure to Large Cap Developed markets Equities.

Which benchmark or index does PBPH replicate?

PBPH tracks the BITA Global Pharma and Biotech Select GRT Index - USD, through a full replication replication method.

What is the Total Expense ratio (TER) of PBPH?

PBPH carries a total expense ratio (TER) of 0.13%, indicating the annual cost for holding the fund.

When was PBPH launched?

PBPH was introduced to the market on November 24, 2025. It trades on United States

Who is the ETF issuer of PBPH?

Portfolio Building Block World Pharma and Biotech Index ETF, PBPH, is provided by Tidal. Learn more about Tidal here.

What is the current assets under management (AUM) of PBPH?

PBPH oversees €586M in assets as of March 9, 2026.

How has PBPH performed lately?

Based on data from March 9, 2026, PBPH returned -3.06% over the past month, 7.45% over the last three months and 3.00% year-to-date.

What are the latest inflows or outflows for PBPH?

As of March 9, 2026, PBPH recorded net flows of +€557M over the last month and +€596M year-to-date.

Does PBPH distribute dividends?

PBPH follows a distributing dividend policy, meaning it pays out income to investors.

What are the main country or region exposures of PBPH?

As of January 31, 2026, PBPH has significant geographic allocations in USA, Switzerland and Denmark.

In which sector or theme does PBPH invest in?

As of January 31, 2026, PBPH focuses largely on Health Care and Consumer Staples.

How many securities does PBPH hold and how diversified is it?

As of January 31, 2026, PBPH holds 49 positions in its portfolio, with 73.19% of assets concentrated in its top 15 holdings.

What are the main positions in PBPH?

As of January 31, 2026, PBPH top three holdings include LILLY, JOHNSON&JOHNSON and ABBVIE.

What is the base currency of PBPH?

The base currency of PBPH is USD.

Advertisement

Trackinsight

About Trackinsight

Since our founding in 2016, we have been at the forefront of the industry, delivering accessible, comprehensive, and reliable tools to support the evolving needs of investors.

Over the past decade, Trackinsight has expanded its operations across six countries, serving thousands of professional investors. We’ve consistently innovated to provide cutting-edge solutions that meet the changing demands of the ETF market.

In 2024, Kepler Cheuvreux, a leading independent European financial services firm, acquired a majority stake in Trackinsight, becoming the company's principal shareholder.

This strategic partnership solidifies Trackinsight's position as a premier provider of ETF selection and analysis tools, while strengthening Kepler Cheuvreux’s commitment to becoming a leading player in the ETF sector.

Together, we are committed to offering advanced services that empower professional investors, advisors, institutions, and issuers. This new step enables us to deliver even more comprehensive and innovative technological solutions, driving ETF investing to new heights.

More about Trackinsight
© 2014-2026 Trackinsight SA. All rights reserved.
Privacy policy  |  Cookie policy  |    |  Terms of use  |  Imprint
Trackinsight